NCT03046329
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Neoplasms, Plasma Cell
Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.
2,604 public trials
547 recruiting studies
Neoplasms, Plasma Cell trial results
NCT01541644
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- University of Maryland Marlene & Stewart Greenebaum Cancer Center Baltimore, Maryland, United States
NCT00105001
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
NCT00834665
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Greenbaum Cancer Center Baltimore, Maryland, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00436618
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Mayo Clinic - Jacksonville Jacksonville, Florida, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
Completed
Lenalidomide and High Dose Melphalan Followed by Autologous Stem Cell Transplant in Multiple Myeloma
NCT01142232
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- IU Simon Cancer Center Indianapolis, Indiana, United States
Completed
Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma
NCT00657488
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Hopital St Joseph Gilly, Belgium
- UCL de Mont Godine Yvoir, Belgium
- Chu D'Angers - Medecine D Angers, France
- Centre Hospitalier D'Annecy - Service d'oncohématologie Annecy, France
NCT00003402
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
NCT01076543
- Conditions
- AIDS-Related Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +27 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
NCT01429025
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States
- Mercy Cancer Center-West Lakes Clive, Iowa, United States
- Iowa Methodist Medical Center Des Moines, Iowa, United States
- Iowa Oncology Research Association CCOP Des Moines, Iowa, United States